AI Discovery & Commercial Visibility
Your next customer may never search Google. They may ask AI instead.
Procurement and business development teams increasingly use ChatGPT, Gemini, Claude, Perplexity and Microsoft Copilot to identify manufacturing and research partners — before they visit a single website or send an RFQ. If AI cannot confidently understand your organisation, it cannot recommend you.
A buyer, right now, could be asking
Where buyers increasingly begin partner discovery
ChatGPT
Gemini
Claude
Perplexity
Copilot
Has buyer behaviour changed?
The path to a shortlist has quietly been rewritten
Buyers still end up at an RFQ and a meeting. But how they get there — and who they consider along the way — now runs through an AI conversation most suppliers never see.
If your company is not included in the AI-generated shortlist, you may never enter the buying process. There is no RFQ to lose — you are simply never asked.
Why does it matter to my company?
Being excluded from AI's answer has become a commercial risk, not a technical one
Why should I trust Emerivo?
A specialist built for one category, not a generalist agency
Specialised for Pharmaceutical Organisations
We work exclusively with TPMs, CMOs, CDMOs and CROs. Pharmaceutical manufacturing and research is a highly specific domain — regulatory nuance, certifications and buyer language all matter, and generalist agencies routinely miss them.
We Execute
We do not hand over a slide deck and disappear. Our team restructures websites, rewrites content and implements the changes required to improve AI understanding — from strategy through to execution.
Continuous Monitoring
AI models are updated constantly, and buyer questions evolve. We continuously re-test your visibility and keep refining your positioning, rather than treating AI discovery as a one-time project.
How does Emerivo solve this?
A disciplined, six-stage methodology — not a one-off report
We move from understanding your current AI visibility through to execution and continuous measurement.
Audit Current AI Visibility
We test how ChatGPT, Gemini, Claude, Perplexity and Microsoft Copilot currently describe your organisation — and whether they mention you at all when buyers ask relevant questions.
Understand Buyer Questions
We map the real questions procurement, sourcing and BD teams ask when searching for a partner like you — by certification, capability, therapeutic area and market.
Improve AI Understanding
We restructure your website and public content so AI can extract clear, specific facts about your certifications, capacity and capabilities — not vague marketing language.
Build Industry Authority
We strengthen the third-party information AI relies on beyond your website — directories, industry publications and credible external sources that reinforce who you are.
Measure AI Discovery
We re-test your visibility against the same buyer questions on a regular schedule, so you can see, in plain terms, whether AI understanding is improving.
Continuously Optimise
AI models change constantly. We keep refining your content and positioning as models evolve, so your visibility holds and improves over time.
Who does this apply to?
Built exclusively for four types of pharmaceutical organisations
Third-Party Manufacturers
Buyers evaluating third-party manufacturing partners want clarity on certifications, dosage forms and capacity — fast. We make sure AI can give it to them, accurately.
Contract Manufacturing Organisations
CMOs compete on scale, reliability and specific manufacturing capability. AI needs to understand exactly what you make and for whom — not a generic description.
Contract Development & Manufacturing Organisations
CDMO buyers ask nuanced questions spanning development and manufacturing. We ensure AI understands both halves of your offering, correctly and specifically.
Contract Research Organisations
Research partners are chosen on therapeutic expertise and regulatory track record. We help AI correctly represent your study experience and specialisation.
What evidence supports that?
A knowledge-first company, not just a services vendor
Our original research and AI Discovery Reports™ are how we build and prove our methodology — publicly, not behind a sales call.
Proprietary analysis of how AI evaluates pharma suppliers
See how ChatGPT, Gemini, Claude, Perplexity and Microsoft Copilot actually describe companies in categories like sterile injectable CDMOs.
View sample reportsBuyer behaviour and AI discovery insights
Original research on how pharmaceutical buyers are changing the way they identify manufacturing and research partners.
Read the researchSee the methodology applied, step by step
Illustrative before-and-after examples showing how we restructure content so AI can understand it.
See demonstrationsWhat should I do next?
Frequently asked questions
An AI Discovery Audit™ is a structured assessment of how ChatGPT, Gemini, Claude, Perplexity and Microsoft Copilot currently understand and describe your organisation, tested against the real questions buyers ask when searching for a manufacturing or research partner in your category.
Search engine optimisation is built to improve ranking on a results page. AI discovery is a different discipline: it is about ensuring AI models can accurately understand and confidently recommend your organisation when a buyer asks a relevant question, drawing on far more than just your own website.
Yes. Emerivo executes the work — website restructuring, content updates and industry authority building — rather than only providing recommendations. Execution is core to how we work.
Initial AI Discovery Audits™ typically take a few weeks. Improving AI understanding and building industry authority is an ongoing process, and most clients see the clearest gains over a sustained engagement measured in months, not days.
No. No credible company can. What we guarantee is disciplined execution, transparent measurement and continuous improvement — not specific rankings or guaranteed mentions, which no one honestly controls.
Because pharmaceutical partner discovery is highly specialised, highly regulated, and requires deep domain understanding. Serving only TPMs, CMOs, CDMOs and CROs lets us build genuine expertise in this category rather than spreading generalist knowledge thin.
Find out how buyers currently discover your organisation through AI
An AI Discovery Audit™ shows you, in plain terms, whether ChatGPT, Gemini, Claude, Perplexity and Microsoft Copilot understand and recommend your company today.